APA (7th ed.) Citation

(2020). Outcome of myeloma patients with COVID5 19 on active lenalidomide-based therapy: 6 Does lenalidomide protect from severe 7 COVID-19?

Chicago Style (17th ed.) Citation

Outcome of Myeloma Patients with COVID5 19 on Active Lenalidomide-based Therapy: 6 Does Lenalidomide Protect from Severe 7 COVID-19? 2020.

MLA (8th ed.) Citation

Outcome of Myeloma Patients with COVID5 19 on Active Lenalidomide-based Therapy: 6 Does Lenalidomide Protect from Severe 7 COVID-19? 2020.

Warning: These citations may not always be 100% accurate.